Editorial | Hong Kong’s world-first Alzheimer’s blood test will strengthen city’s healthcare

Hong Kong has pioneered a revolutionary blood test capable of detecting Alzheimer's disease at its earliest stages, representing a significant advancement in preventive healthcare. This innovative screening method enables medical professionals to identify cognitive decline markers before symptoms manifest, facilitating timely intervention and treatment planning. The development reinforces Hong Kong's commitment to proactive health management and positions the city as a leader in cutting-edge medical diagnostics, ultimately improving patient outcomes and quality of life.